Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics
- 1 January 2006
- journal article
- Published by Elsevier BV in Schizophrenia Research
- Vol. 81 (2-3), 291-300
- https://doi.org/10.1016/j.schres.2005.10.011
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Supplementation with a combination of ω-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophreniaSchizophrenia Research, 2003
- Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movementsSchizophrenia Research, 2003
- Reduced plasma antioxidants in first-episode patients with schizophreniaSchizophrenia Research, 2003
- Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychoticsSchizophrenia Research, 2002
- Oxidative Damage and SchizophreniaCNS Drugs, 2001
- Free radical pathology in schizophrenia: a reviewProstaglandins, Leukotrienes & Essential Fatty Acids, 1996
- Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatmentInternational Clinical Psychopharmacology, 1993
- Fatty acid levels in the brains of schizophrenics and normal controlsBiological Psychiatry, 1991
- Enzymes of the antioxidant defense system in chronic schizophrenic patientsBiological Psychiatry, 1991
- Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesiaBiological Psychiatry, 1990